Company intelligence / Profile preview

PBS Biotech

Camarillo, California, United States

Ownership: Private
Development stage: Commercial

Overview

PBS Biotech does not develop its own therapeutics but enables the scalable production of allogeneic cell therapies with its proprietary Vertical-Wheel single-use bioreactor systems. The company’s products are widely adopted in the industry and supported by published studies demonstrating superior performance versus traditional stirred-tank reactors—especially with sensitive or aggregate-forming cell types like iPSCs and MSCs. Their contract process development services further support customers’ transition from R&D to clinical/commercial scale-up.

Therapeutic areas: OtherOncologyEndocrinologyCardiovascular
Modalities: Cell therapyDevicePlatform technology
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on PBS Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PBS Biotech.

Explore the full profile